Grasse BIOTECH

grassebiotech.fr

Grasse BIOTECH - Hotel of innovation companies and support of startups in the field of cosmetologies, biotechnologies, health, life sciences and scientific research and analysis activities of the Pays de Grasse, benefits from added value linked to a privileged project accelerator environment. On the ArômaGrasse Business Park where are hosted more than 15 companies such as: Perfume Cosmetic World, TOMCOS, SelectArôme ... mostly PASS (Perfumes, Aromas, Scents, Flavors). In connection with Espace Jacques-Louis Lions where are located: o the InnovaGrasse business incubator, o the University of Nice Sophia-Antipolis: training in fine chemistry master 2 FOQUAL, its students, professors and researchers in a place conducive to teaching and research (classrooms, laboratories, exchange rooms ...), o Technological and regulatory resources represented by the PASS Competitiveness Cluster and its partnership analytical chemistry platform, whose objective is to strengthen R & D by bringing researchers from the academic sector and the private sector together in a single location (certification and authentication). ingredients). In an already existing network of support for creation and innovation, Grasse BIOTECH thus makes it possible to cover the entire chain of support to businesses: from creation to their long-term presence on the territory of the Communauté d'Agglomération du Pays de Grasse. Grasse BIOTECH is funded with the support of the European Union with the European Regional Development Fund, the Regional Council PACA and the Departmental Council of the Alpes-Maritimes.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

SALIPRO BIOTECH OBTAINS GRANTED PATENTS IN THE UNITED STATES AND CHINA FOR DIRECT EXTRACTION OF MEMBRANE PROTEINS AND LIBRARY GENERATION

Salipro Biotech | September 08, 2022

news image

Salipro Biotech AB, a Swedish biotech company with a leading technology platform for the stabilization of membrane proteins for drug development, announced today that its patent entitled "Saposin lipoprotein particles and libraries from crude membranes" has been issued by both the U.S. Patent and Trademark Office and by the China National Intellectual Property Administration. The patents cover the company's novel method of direct extraction of membrane proteins from cells or crude ...

Read More

RESEARCH

POSTERA ANNOUNCES $260M MULTI-TARGET STRATEGIC AI LAB COLLABORATION WITH PFIZER

PostEra | January 12, 2022

news image

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced the expansion of the company's existing strategic collaboration with Pfizer. The expanded multi-target research program will establish an AI Lab where PostEra and Pfizer jointly advance multiple drug discovery programs with an initial focus in oncology and COVID-19 antiviral therapeutics. The AI Lab will leverage novel machine learning for medicinal chemistry built upon Pfizer's da...

Read More

INDUSTRIAL IMPACT

MINDMED ANNOUNCES TRANSITIONS TO MANAGEMENT TEAM

Mind Medicine (MindMed) Inc. | December 30, 2021

news image

Mind Medicine Inc. a leading biotech company developing psychedelic-inspired therapies, announced that its Chief Technology Officer, Bradford Cross, has transitioned from his role. "On behalf of the Board of Directors and Executive team, I would like to thank Bradford for his contributions to the Company and wish him all the best in his future endeavors. We remain dedicated to advancing our pipeline and ongoing digital therapeutics platform forward under...

Read More

RESEARCH

ALIVAMAB DISCOVERY SERVICES IS EXPANDING THE DRUG DISCOVERY PLATFORM WITH THE INTRODUCTION OF NEW ANTIBODY ENGINEERING DEPARTMENT

AlivaMab | May 13, 2021

news image

AlivaMab Discovery Services, LLC ("ADS"), a pioneer in the discovery of superior antibody therapeutics, announced today the formation of its new Antibody Engineering Department, headed by Jonah Rainey, Ph.D. Jonah joins ADS as Vice President of Antibody Engineering, bringing 15 years of experience from Macrogenics Inc. in antibody engineering, discovery, and development, MedImmune, LLC/AstraZeneca PLC, Gritstone Bio, Inc., and, most recently, Immetas Therapeutics, Inc. Jonah's expe...

Read More
news image

MEDICAL

SALIPRO BIOTECH OBTAINS GRANTED PATENTS IN THE UNITED STATES AND CHINA FOR DIRECT EXTRACTION OF MEMBRANE PROTEINS AND LIBRARY GENERATION

Salipro Biotech | September 08, 2022

Salipro Biotech AB, a Swedish biotech company with a leading technology platform for the stabilization of membrane proteins for drug development, announced today that its patent entitled "Saposin lipoprotein particles and libraries from crude membranes" has been issued by both the U.S. Patent and Trademark Office and by the China National Intellectual Property Administration. The patents cover the company's novel method of direct extraction of membrane proteins from cells or crude ...

Read More
news image

RESEARCH

POSTERA ANNOUNCES $260M MULTI-TARGET STRATEGIC AI LAB COLLABORATION WITH PFIZER

PostEra | January 12, 2022

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced the expansion of the company's existing strategic collaboration with Pfizer. The expanded multi-target research program will establish an AI Lab where PostEra and Pfizer jointly advance multiple drug discovery programs with an initial focus in oncology and COVID-19 antiviral therapeutics. The AI Lab will leverage novel machine learning for medicinal chemistry built upon Pfizer's da...

Read More
news image

INDUSTRIAL IMPACT

MINDMED ANNOUNCES TRANSITIONS TO MANAGEMENT TEAM

Mind Medicine (MindMed) Inc. | December 30, 2021

Mind Medicine Inc. a leading biotech company developing psychedelic-inspired therapies, announced that its Chief Technology Officer, Bradford Cross, has transitioned from his role. "On behalf of the Board of Directors and Executive team, I would like to thank Bradford for his contributions to the Company and wish him all the best in his future endeavors. We remain dedicated to advancing our pipeline and ongoing digital therapeutics platform forward under...

Read More
news image

RESEARCH

ALIVAMAB DISCOVERY SERVICES IS EXPANDING THE DRUG DISCOVERY PLATFORM WITH THE INTRODUCTION OF NEW ANTIBODY ENGINEERING DEPARTMENT

AlivaMab | May 13, 2021

AlivaMab Discovery Services, LLC ("ADS"), a pioneer in the discovery of superior antibody therapeutics, announced today the formation of its new Antibody Engineering Department, headed by Jonah Rainey, Ph.D. Jonah joins ADS as Vice President of Antibody Engineering, bringing 15 years of experience from Macrogenics Inc. in antibody engineering, discovery, and development, MedImmune, LLC/AstraZeneca PLC, Gritstone Bio, Inc., and, most recently, Immetas Therapeutics, Inc. Jonah's expe...

Read More